drugset / Trial / NCT00003980

BIBX 1382 in Treating Patients With Solid Tumors

NCT00003980 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BIBX 1382 in treating patients who have solid tumors.

Timeline

Start
1999-02
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject FALNIDAMOL Small molecule — Intravenous